NATURE’S SUNSHINE PRODUCTS, INC. Long-term Debt and Lease Obligation, Current
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Long-term Debt and Lease Obligation, Current of $1.01 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent · last filed 2023-05-09
- 2023-03-31: Long-term Debt and Lease Obligation, Current $1.01M.
- 2022-12-31: Long-term Debt and Lease Obligation, Current $1.17M.
- 2022-09-30: Long-term Debt and Lease Obligation, Current $1.27M.
- 2022-06-30: Long-term Debt and Lease Obligation, Current $1.26M.
| Period end | Long-term Debt and Lease Obligation, Current |
|---|---|
| 2023-03-31 | $1.01M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.17M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $1.27M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.26M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.25M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.24M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $1.24M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.23M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.22M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.31M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $3.31M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.41M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |